Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TLV/BIOV stock hub

TLV/BIOV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/BIOVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

21.6M

Tel Aviv Stock Exchange

Market data

Price

Recent price action with selectable time range.

TLV/BIOVTLV/BIOV

—

Loading chart…

In the news

Latest news · TLV/BIOV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-94.8

P25 n/aP50 n/aP75 n/a

ROIC-155.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/BIOV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

ILS

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	31
Employees Change	-2%
Employees Change Percent	-6.06
Enterprise value	ILA 17.1M
Exchange	Tel Aviv Stock Exchange
Financial currency	ILS
First seen	2026-05-10
Industry	Medical Devices
Isin	IL0010960495
Last refreshed	2026-05-10
Market cap	ILA 21.6M
Price	ILA 16.1
Price currency	ILA
Rev Per Employee	664,333.33x
Sector	Healthcare
Sic	3845
Symbol	tlv/BIOV
Website	https://www.bioview.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-71.06%
EV Earnings	-1.12x
EV/FCF	-5.51x
EV/Sales	0.86x
FCF yield	-14.41%
P/B ratio	2.29x
P/S ratio	1.08x
PE Ratio10 Y	49.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-38.89%
EBITDA Margin	-36.86%
Gross margin	47.76%
Gross Profit	ILA 9.5M
Gross Profit Growth	14.83%
Gross Profit Growth Q	30.09%
Gross Profit Growth3 Y	-24.68%
Gross Profit Growth5 Y	-14%
Net Income	ILA -15.3M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-45.9%
Profit Margin	-76.93%
Profit Per Employee	ILA -511,067
ROA	-18.11
Roa5y	-3.67
ROCE	-68.68
ROE	-94.76
Roe5y	-19.09
ROIC	-155.4
Roic5y	-16.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.7%
Cagr15y	-1.87%
Cagr1y	-39.95%
Cagr20y	-6.47%
Cagr3y	-22.77%
Cagr5y	-12.5%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	-22.32x
Revenue Growth Q	23.79x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-16.59x
Revenue Growth5 Y	-10.19x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 0.74
Assets	ILA 19.9M
Cash	ILA 7.2M
Current Assets	ILA 16.2M
Current Liabilities	ILA 8.6M
Debt	ILA 2.8M
Debt Equity	ILA 0.3
Debt FCF	ILA -0.9
Equity	ILA 9.4M
Interest Coverage	-65.13
Liabilities	ILA 10.5M
Long Term Assets	ILA 3.7M
Long Term Liabilities	ILA 1.9M
Net Cash	ILA 4.4M
Net Cash By Market Cap	ILA 20.51
Net Cash Growth	-50.59%
Net Debt Equity	ILA -0.47
Tangible Book Value	ILA 9.4M
Tangible Book Value Per Share	ILA 0.07
WACC	4.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.88
Inventory Turnover	1.44
Net Working Capital	ILA 1.6M
Quick ratio	1.13
Working Capital	ILA 7.6M
Working Capital Turnover	ILA 1.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.13%
Dividend per share	ILA 0
Last Dividend	ILA 0.02

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-55.12%
1Y total return	-39.93%
200-day SMA	18.21
3Y total return	-53.95%
50-day SMA	16.15
50-day SMA vs 200-day SMA	50under200
5Y total return	-48.71%
All Time High	71.35
All Time High Change	-77.44%
All Time High Date	2006-03-16
All Time Low	2.4
All Time Low Change	570.83%
All Time Low Date	2008-12-08
ATR	0.76
Beta	0.06
Beta1y	-0.08
Beta2y	-0.33
Ch YTD	-3.59
High	16.4
High52	29.4
High52 Date	2026-01-06
High52ch	-45.24%
Low	16.1
Low52	12.9
Low52 Date	2025-11-16
Low52ch	24.81%
Ma50ch	-0.28%
Price vs 200-day SMA	-11.57%
RSI	51.03
RSI Monthly	38.96
RSI Weekly	42.28
Sharpe ratio	-0.64x
Sortino ratio	-0.83
Total Return	-2.13%
Tr YTD	-3.59
Tr15y	-24.62%
Tr1m	14.18%
Tr1w	-0.62%
Tr3m	-10.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA -7.8M
Operating margin	-38.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	66,760,443%
Net Borrowing	-1,704,000
Shares Insiders	50.18%
Shares Institutions	16.71%
Shares Out	134,007,627
Shares Qo Q	4.97%
Shares Yo Y	2.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA -3.5M
Average Volume	174,860.6x
Bv Per Share	0.07
CAPEX	ILA -53,000
Ch10y	-57.25
Ch15y	-28.19
Ch1m	14.18
Ch1w	-0.62
Ch1y	-39.93
Ch20y	-75
Ch3m	-10.06
Ch3y	-53.95
Ch5y	-48.71
Ch6m	14.18
Change	0%
Change From Open	-1.83
Close	16.1
Days Gap	1.86
Depreciation Amortization	405,000
Dollar Volume	322,000
Earnings Date	2026-04-10
EBIT	ILA -7.8M
EBITDA	ILA -7.3M
EPS	ILA -0.11
F Score	3
FCF	ILA -3.1M
FCF EV Yield	-18.13x
FCF Per Share	ILA -0.02
Financing CF	425,000
Fiscal Year End	December
Founded	1,998
Income Tax	ILA 6.2M
Investing CF	255,000
Is Primary Listing	1
Last Earnings Date	2025-11-30
Last Report Date	2025-12-31
Last Split Date	2023-12-24
Last Split Type	Forward
Ma150	16.81
Ma150ch	-4.2%
Ma20	15.74
Ma20ch	2.29%
Net CF	-3,300,000
Open	16.4
Position In Range	0
Ppne	3,251,000
Price Date	2026-05-05
Ptbv Ratio	2.29
Relative Volume	0.11x
Revenue	19,930,000x
SBC By Revenue	2.11x
Share Based Comp	420,000
Tax By Revenue	31.03x
Tr20y	-73.76%
Tr6m	14.18%
Volume	20,000
Z Score	-1.05

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TLV/BIOV pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/BIOV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/BIOV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.7%

Share of float held by funds and institutions

Insider ownership

+50.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.1%

Negative means the company is buying back shares.

Technical

TLV/BIOV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.0

Neutral momentum band

Price vs 200-day MA

-11.6%

50/200-day relationship not available

Beta (5Y)

0.06

Less volatile than the market

Sharpe ratio

-0.64

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/BIOV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/BIOV stock rating?

tlv/BIOV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/BIOV analysis?

The full report lives at /stocks/tlv/BIOV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/BIOV?

The latest report frames tlv/BIOV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/BIOV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.